ILC Therapeutics

United Kingdom
Newhouse, North Lanarkshire, United Kingdom, ML1 5UH

Company profile

ILC Therapeutics company profile

ILC Therapeutics Ltd is an early-stage biotechnology company focused on modulating the Innate Immune System through the development of novel peptide therapeutics for the treatment of Covid-19, Cancer, Atopic Dermatitis, and Psoriasis.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2012-01-01, Year

Headquarters

Postal code
ML1 5UH
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$8.1M
Last funding
Series Unknown / $3.3M / 2024-09-11
Last equity funding
Series Unknown / $3.3M
Investors
4
Lead investors
3
Founders
2
Articles
16

Founders and investors

Founders

Alistair StrachanWilliam Stimson

Lead investors

EOS Technology Investment SyndicateMedical Incubator JapanRobert Kopple

Investors

EOS Technology Investment SyndicateMedical Incubator JapanRobert KoppleScottish Enterprise